BCHE and Alzheimer disease: Worse proxy QoL ratings (n = 146) correlated with worse dementia severity, daytime sleepiness, behavioral symptoms, an inability to complete ADLs, and whether patient was taking a cholinesterase inhibitor (higher QoL‐AD scores in the group taking a cholinesterase inhibitor; Table 3).